Anti-Cancer Drugs

An international journal on anti-cancer agents

Anti-Cancer Drugs focuses on the clinical and experimental effects of toxic and non-toxic cancer agents, and specifically highlights breakthroughs in cancer treatment.
Subjects range from cytotoxic chemotherapy, hormonal or biological response modifiers such as interleukins, immunotherapy, drug design, drug delivery, adverse effects of drugs and drug resistance.
Strong emphasis is placed on papers concerned with treatments to alleviate the side-effects of chemotherapy, a subject all too often overlooked.

*

Editor:
Mels Sluyser, The Netherlands Cancer Institute, Amsterdam, The Netherlands

*

chapman and hall